Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read
Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

Photo by Jetcityimage via iStock

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

Photo by Chemist4U via CC BY-SA 2.0

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Photo by News Øresund – Johan Wessman via CC BY 2.0

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read